Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 995

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance

Yang, Chung S., Wang, Xin, Lu, Gang, Picinich, Sonia C.·2009·Nature Reviews Cancer
DOI 10.1038/nrc2641
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrc2641

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 113

  1. Yang, C. S. & Wang, Z. Y. Tea and cancer. J. Natl Cancer Inst. 85, 1038–1049 (1993). This is the first comprehensive review of the cancer preventive activities of tea. · DOI
  2. Bushman, J. L. Green tea and cancer in humans: a review of the literature. Nutr. Cancer 31, 151–159 (1998). · DOI
  3. Yang, C. S., Maliakal, P. & Meng, X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42, 25–54 (2002). · DOI · Paper page
  4. Hou, Z., Lambert, J. D., Chin, K. V. & Yang, C. S. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat. Res. 555, 3–19 (2004). · DOI
  5. Lambert, J. D., Hong, J., Yang, G. Y., Liao, J. & Yang, C. S. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr. 81, 284S–291S (2005). · DOI
  6. Clark, J. & You, M. Chemoprevention of lung cancer by tea. Mol. Nutr. Food Res. 50, 144–151 (2006). · DOI
  7. Khan, N., Afaq, F., Saleem, M., Ahmad, N. & Mukhtar, H. Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate. Cancer Res. 66, 2500–2505 (2006). · DOI · Paper page
  8. Wu, A. H. & Yu, M. C. Tea, hormone-related cancers and endogenous hormone levels. Mol. Nutr. Food Res. 50, 160–169 (2006). · DOI
  9. Yang, C. S. et al. Possible mechanisms of the cancer-preventive activities of green tea. Mol. Nutr. Food Res. 50, 170–175 (2006). · DOI
  10. Ju, J., Lu, G., Lambert, J. D. & Yang, C. S. Inhibition of carcinogenesis by tea constituents. Semin. Cancer Biol. 17, 395–402 (2007). · DOI
  11. Balentine, D. A., Wiseman, S. A. & Bouwens, L. C. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 37, 693–704 (1997). This is a comprehensive review of the composition of different types of tea and the chemistry of tea constituents. · DOI
  12. Valcic, S., Burr, J. A., Timmermann, B. N. & Liebler, D. C. Antioxidant chemistry of green tea catechins. New oxidation products of (−)-epigallocatechin gallate and (−)-epigallocatechin from their reactions with peroxyl radicals. Chem. Res. Toxicol. 13, 801–810 (2000). · DOI
  13. Sang, S. M. et al. Theadibenzotropolone A, a new type pigment from enzymatic oxidation of (−)-epicatechin and (−)-epigallocatechin gallate and characterized from black tea using LC/MS/MS. Tetrahedron Lett. 43, 7129–7133 (2002). · DOI
  14. Hou, Z. et al. Mechanism of action of (−)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 65, 8049–8056 (2005). · DOI
  15. Lee, M. J. et al. Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 11, 1025–1032 (2002).
  16. Chow, H. H. et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 9, 3312–3319 (2003). This article reports the detailed pharmacokinetics and safety of green tea polyphenols in humans.
  17. Chen, L., Lee, M. J., Li, H. & Yang, C. S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab. Dispos. 25, 1045–1050 (1997).
  18. Lambert, J. D. et al. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos. 34, 8–11 (2006). · DOI
  19. Yang, C. S., Sang, S., Lambert, J. D. & Lee, M. J. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol. Nutr. Food Res. 52 (Suppl. 1), 139–151 (2008).
  20. Wang, Z. Y. et al. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 52, 1943–1947 (1992). This is the first publication demonstrating the inhibition of lung carcinogenesis by green and black tea.
  21. Xu, Y., Ho, C. T., Amin, S. G., Han, C. & Chung, F. L. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 52, 3875–3879 (1992). This is the first demonstration of the inhibition of lung tumorigenesis by EGCG and caffeine.
  22. Yang, G. Y. et al. Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. Carcinogenesis 18, 2361–2365 (1997). · DOI
  23. Chung, F. L. et al. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res. 58, 4096–4101 (1998).
  24. Mimoto, J. et al. (−)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice. Carcinogenesis 21, 915–919 (2000). · DOI
  25. Zhang, Z. et al. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res. 60, 901–907 (2000).
  26. Liao, J. et al. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr. Cancer 48, 44–53 (2004). · DOI
  27. Schuller, H. M., Porter, B., Riechert, A., Walker, K. & Schmoyer, R. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer 45, 11–18 (2004). · DOI
  28. Lu, G. et al. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res. 66, 11494–11501 (2006). · DOI
  29. Landau, J. M., Wang, Z. Y., Yang, G. Y., Ding, W. & Yang, C. S. Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis 19, 501–507 (1998). · DOI
  30. Sazuka, M., Murakami, S., Isemura, M., Satoh, K. & Nukiwa, T. Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett. 98, 27–31 (1995). · DOI
  31. Lu, G. et al. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin. Cancer Res. 14, 4981–4988 (2008). · DOI
  32. Lu, Y. et al. A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice. Cancer Res. 66, 1956–1963 (2006). · DOI
  33. Li, N. et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23, 1307–1313 (2002). · DOI
  34. Wang, Z. Y. et al. Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 16, 2143–2148 (1995). · DOI
  35. Yamane, T. et al. Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (−)-epigallocatechin gallate in the rat glandular stomach. Cancer Res. 55, 2081–2084 (1995).
  36. Murugan, R. S. et al. Modulatory effects of black tea polyphenols on oxidant–antioxidant profile and expression of proliferation, apoptosis, and angiogenesis-associated proteins in the rat forestomach carcinogenesis model. J. Gastroenterol. 42, 352–361 (2007). · DOI
  37. Ju, J. et al. Inhibition of intestinal tumorigenesis in ApcMin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65, 10623–10631 (2005). · DOI
  38. Hao, X. et al. Inhibition of intestinal tumorigenesis in ApcMin/+ mice by green tea polyphenols (polyphenon E) and individual catechins. Nutr. Cancer 59, 62–69 (2007). · DOI
  39. Xiao, H. et al. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 29, 113–119 (2008). · DOI
  40. Liao, S., Umekita, Y., Guo, J., Kokontis, J. M. & Hiipakka, R. A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 96, 239–243 (1995). · DOI
  41. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S. & Mukhtar, H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl Acad. Sci. USA 98, 10350–10355 (2001). This is the first demonstration of the inhibition of prostate carcinogenesis in a mouse model by green tea polyphenols and related mechanisms. · DOI · Paper page
  42. Adhami, V. M., Siddiqui, I. A., Ahmad, N., Gupta, S. & Mukhtar, H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 64, 8715–8722 (2004). · DOI · Paper page
  43. Gao, Y. T. et al. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86, 855–858 (1994). · DOI
  44. Fujiki, H., Suganuma, M., Imai, K. & Nakachi, K. Green tea: cancer preventive beverage and/or drug. Cancer Lett. 188, 9–13 (2002). · DOI
  45. Zhang, M., Holman, C. D., Huang, J. P. & Xie, X. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 28, 1074–1078 (2007). · DOI
  46. Sun, C. L. et al. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis 23, 1497–1503 (2002). · DOI
  47. Yuan, J. M., Gao, Y. T., Yang, C. S. & Yu, M. C. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int. J. Cancer 120, 1344–1350 (2007). · DOI
  48. Sasazuki, S., Inoue, M., Miura, T., Iwasaki, M. & Tsugane, S. Plasma tea polyphenols and gastric cancer risk: a case-control study nested in a large population-based prospective study in Japan. Cancer Epidemiol. Biomarkers Prev. 17, 343–351 (2008). · DOI
  49. Wu, A. H., Yu, M. C., Tseng, C. C., Hankin, J. & Pike, M. C. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer 106, 574–579 (2003). · DOI
  50. Wu, A. H., Tseng, C. C., Van Den Berg, D. & Yu, M. C. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res. 63, 7526–7529 (2003).
  51. Bonner, M. R. et al. Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer. Mutat. Res. 582, 53–60 (2005). · DOI
  52. Li, N., Sun, Z., Han, C. & Chen, J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc. Soc. Exp. Biol. Med. 220, 218–224 (1999).
  53. Ahn, W. S. et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur. J. Cancer Prev. 12, 383–390 (2003). · DOI
  54. Bettuzzi, S. et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66, 1234–1240 (2006). This is the first demonstration that green tea polyphenols prevented the progression of high-grade PIN to prostate cancer. · DOI · Paper page
  55. Shimizu, M. et al. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 17, 3020–3025 (2008). · DOI · Paper page
  56. Srividhya, R., Jyothilakshmi, V., Arulmathi, K., Senthilkumaran, V. & Kalaiselvi, P. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (−)-epigallocatechin-3-gallate. Int. J. Dev. Neurosci. 26, 217–223 (2008). · DOI
  57. Senthil Kumaran, V., Arulmathi, K., Srividhya, R. & Kalaiselvi, P. Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp. Gerontol. 43, 176–183 (2008). · DOI
  58. Inami, S. et al. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Int. Heart J. 48, 725–732 (2007). · DOI
  59. Hsu, S. P. et al. Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am. J. Clin. Nutr. 86, 1539–1547 (2007). · DOI
  60. Hakim, I. A. et al. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J. Nutr. 133, 3303S–3309S (2003). · DOI
  61. Schwartz, J. L., Baker, V., Larios, E. & Chung, F. L. Molecular and cellular effects of green tea on oral cells of smokers: a pilot study. Mol. Nutr. Food Res. 49, 43–51 (2005). · DOI
  62. Yang, G. Y., Liao, J., Kim, K., Yurkow, E. J. & Yang, C. S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19, 611–616 (1998). · DOI · Paper page
  63. Na, H. K. & Surh, Y. J. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem. Toxicol. 46, 1271–1278 (2008). · DOI · Paper page
  64. Shen, G. et al. Comparison of (−)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/56J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm. Res. 22, 1805–1820 (2005). · DOI
  65. Chow, H. H. et al. Modulation of human glutathione S-transferases by polyphenon E intervention. Cancer Epidemiol. Biomarkers Prev. 16, 1662–1666 (2007). · DOI
  66. Tang, L. et al. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis 29, 411–417 (2008). · DOI
  67. Bonkovsky, H. L. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann. Intern. Med. 144, 68–71 (2006). · DOI · Paper page
  68. Lambert, J. D., Sang, S. & Yang, C. S. Possible controversy over dietary polyphenols: benefits vs risks. Chem. Res. Toxicol. 20, 583–585 (2007). This article discusses possible benefits and risks of taking green tea extract as a dietary supplement. · DOI · Paper page
  69. Tachibana, H., Koga, K., Fujimura, Y. & Yamada, K. A receptor for green tea polyphenol EGCG. Nature Struct. Mol. Biol. 11, 380–381 (2004). This is the first report of the identification of EGCG targets in a cell line. · DOI
  70. Umeda, D., Yano, S., Yamada, K. & Tachibana, H. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J. Biol. Chem. 283, 3050–3058 (2008). · DOI
  71. Leone, M. et al. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 63, 8118–8121 (2003).
  72. Ermakova, S. et al. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J. Biol. Chem. 280, 16882–16890 (2005). This is the first report of the identification of an EGCG target protein by affinity chromatography and molecular studies. · DOI
  73. Li, M. et al. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (−)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol. Biomarkers Prev. 16, 598–605 (2007). · DOI
  74. He, Z. et al. Fyn is a novel target of (−)-epigallocatechin gallate in the inhibition of JB6 C141 cell transformation. Mol. Carcinog. 47, 172–183 (2008). · DOI
  75. Ermakova, S. P. et al. (−)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res. 66, 9260–9269 (2006). · DOI
  76. Shim, J. H. et al. (−)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase. J. Biol. Chem. 283, 28370–28379 (2008). · DOI
  77. Mitsiades, C. S. et al. Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 5, 221–230 (2004). · DOI · Paper page
  78. Shimizu, M., Deguchi, A., Hara, Y., Moriwaki, H. & Weinstein, I. B. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem. Biophys. Res. Commun. 334, 947–953 (2005). · DOI
  79. Vittal, R. et al. Gene expression changes induced by green tea polyphenol (−)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Mol. Cancer Ther. 3, 1091–1099 (2004). · DOI
  80. Dong, Z., Ma, W., Huang, C. & Yang, C. S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (−)-epigallocatechin gallate, and theaflavins. Cancer Res. 57, 4414–4419 (1997).
  81. Chung, J. Y., Huang, C., Meng, X., Dong, Z. & Yang, C. S. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure–activity relationship and mechanisms involved. Cancer Res. 59, 4610–4617 (1999).
  82. Chung, J. Y., Park, J. O., Phyu, H., Dong, Z. & Yang, C. S. Mechanisms of inhibition of the Ras–MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (−)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J. 15, 2022–2024 (2001). · DOI
  83. Liang, Y. C., Lin-Shiau, S. Y., Chen, C. F. & Lin, J. K. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)-epigallocatechin-3-gallate. J. Cell Biochem. 75, 1–12 (1999). · DOI
  84. Nam, S., Smith, D. M. & Dou, Q. P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276, 13322–13330 (2001). · DOI
  85. Gupta, S., Ahmad, N., Nieminen, A. L. & Mukhtar, H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (−)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 164, 82–90 (2000). · DOI
  86. Gupta, S., Hussain, T. & Mukhtar, H. Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch. Biochem. Biophys. 410, 177–185 (2003). · DOI · Paper page
  87. Smith, D. M. et al. Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol. Med. 8, 382–392 (2002). · DOI
  88. Garbisa, S. et al. Tumor invasion: molecular shears blunted by green tea. Nature Med. 5, 1216 (1999). · DOI
  89. Garbisa, S. et al. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91, 822–832 (2001). · DOI
  90. Annabi, B. et al. Green tea polyphenol (−)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta 1542, 209–220 (2002). · DOI
  91. Taniguchi, S. et al. Effect of (−)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett. 65, 51–54 (1992). · DOI
  92. Fang, M. Z. et al. Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563–7570 (2003).
  93. Navarro-Peran, E. et al. The antifolate activity of tea catechins. Cancer Res. 65, 2059–2064 (2005). · DOI
  94. Shin, E. S. et al. Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme. Bioorg. Med. Chem. 16, 3580–3586 (2008). · DOI
  95. Ishii, T. et al. Covalent modification of proteins by green tea polyphenol (−)-epigallocatechin-3-gallate through autoxidation. Free Radic. Biol. Med. 45, 1384–1394 (2008). · DOI
  96. Lo, H. W. & Hung, M. C. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br. J. Cancer 94, 184–188 (2006). · DOI
  97. Liang, Y. C., Lin-shiau, S. Y., Chen, C. F. & Lin, J. K. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell Biochem. 67, 55–65 (1997). · DOI
  98. Shimizu, M. et al. (−)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res. 11, 2735–2746 (2005). · DOI · Paper page
  99. Adachi, S. et al. The inhibitory effect of (−)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 67, 6493–6501 (2007). · DOI
  100. Adachi, S. et al. (−)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis 29, 1986–1993 (2008). · DOI
  101. Masuda, M. et al. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J. Exp. Ther. Oncol. 2, 350–359 (2002). · DOI
  102. Peschard, P. & Park, M. From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 26, 1276–1285 (2007). · DOI
  103. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G. F. Met, metastasis, motility and more. Nature Rev. Mol. Cell Biol. 4, 915–925 (2003). · DOI
  104. Bigelow, R. L. & Cardelli, J. A. The green tea catechins, (−)-Epigallocatechin-3-gallate (EGCG) and (−)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 25, 1922–1930 (2006). · DOI
  105. Lim, Y. C. et al. (−)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett. 271, 140–152 (2008). · DOI
  106. Sartippour, M. R. et al. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr. 132, 2307–2311 (2002). · DOI
  107. Rodriguez, S. K. et al. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int. J. Cancer 118, 1635–1644 (2006). · DOI
  108. Zhu, B. H. et al. (−)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J. Gastroenterol. 13, 1162–1169 (2007). · DOI
  109. Sukhthankar, M. et al. A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology 134, 1972–1980 (2008). · DOI
  110. Ciardiello, F. et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin. Cancer Res. 7, 1459–1465 (2001).
  111. Weinstein, I. B. & Joe, A. Oncogene addiction. Cancer Res. 68, 3077–3080; discussion 3080 (2008). · DOI · Paper page
  112. Stoner, G. D. et al. Cancer prevention with freeze-dried berries and berry components. Semin. Cancer Biol. 17, 403–410 (2007). · DOI
  113. Shumway, B. S. et al. Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin. Cancer Res. 14, 2421–2430 (2008). · DOI

Cited by

Metadata

Authors
Yang, C. S., Wang, X., Lu, G., & Picinich, S. C.
Venue
Nature Reviews Cancer
Publisher
Springer Science and Business Media LLC
Published
2009-05-14
Volume
9
Issue
6
Pages
429-439
ISSN
  • 1474-175X
  • 1474-1768
DOI
10.1038/nrc2641
Cited by
995
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.